Aquestive Therapeutics Inc. (AQST)
NASDAQ
Aquestive Therapeutics Inc. Total Liabilities 2017–2025
Aquestive Therapeutics Inc. annual/quarterly total liabilities history from 2017 to 2025. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Aquestive Therapeutics Inc. total liabilities for the quarter ending December 31, 2025 were 194.1M, a 20.12% increase year-over-year.
- Aquestive Therapeutics Inc. total liabilities for 2025 were 194.1M, a 20.12% increase from 2024.
- Aquestive Therapeutics Inc. total liabilities for 2024 were 161.6M, a 1.42% decrease from 2023.
- Aquestive Therapeutics Inc. total liabilities for 2023 were 163.9M, a 6.67% decrease from 2022.
- Aquestive Therapeutics Inc. total liabilities for 2022 were 175.6M.
Total Liabilities
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Aquestive Therapeutics Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2025 | $194 |
| 2024 | $162 |
| 2023 | $164 |
| 2022 | $176 |
| 2021 | $144 |
| 2020 | $111 |
| 2019 | $85 |
| 2018 | $77 |
| 2017 | $70 |
| Aquestive Therapeutics Inc. Quarterly Total Liabilities (Millions of US $) | |
|---|---|
| 2025-12-31 | $194 |
| 2024-12-31 | $162 |
| 2023-12-31 | $164 |
| 2022-12-31 | $176 |
| 2021-12-31 | $144 |
| 2020-12-31 | $111 |
| 2019-12-31 | $85 |
| 2018-12-31 | $77 |
| 2017-12-31 | $70 |
Aquestive Therapeutics Inc. Total Liabilities — FAQ
Aquestive Therapeutics Inc. (AQST) total liabilities over the last 9 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AQST's total liabilities history?
The chart and table above show Aquestive Therapeutics Inc.'s total liabilities by year and by quarter, including the growth rate.